Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Kevin H. Kuo"'
Autor:
Antonis Kattamis, Soo-Min Lim, Silverio Perrotta, Jeevan K Shetty, Yesim Aydinok, Matthew L. Sherman, Kevin H. Kuo, Ersi Voskaridou, John Porter, Gian Luca Forni, Vip Viprakasit, Peter G. Linde, Abderrahmane Laadem, Pencho Georgiev, Jun Zou, Mohamed Bejaoui, Lee-Ping Chew, Meng-Yao Lu, Efthymia Vlachaki, Penka Ganeva, Believe Investigators, Ashutosh Lal, Olivier Hermine, Idit Pazgal-Kobrowski, Antonio Piga, Farrukh Shah, M. Domenica Cappellini, Liana Gercheva, Alexis A. Thompson, Ali T Taher, Adisak Tantiworawit, Raffaella Origa, Ellis J Neufeld, Abderrahim Khelif, P Joy Ho, Thomas D. Coates, Jennie Zhang, Hong-Keng Liew, Ping Chong Bee, Dimana Miteva, Tatiana Zinger
BACKGROUND Patients with transfusion-dependent ?-thalassemia need regular red-cell transfusions. Luspatercept, a recombinant fusion protein that binds to select transforming growth factor ? superfamily ligands, may enhance erythroid maturation and re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4fe5db0b5c20202be3afeae19191200
http://hdl.handle.net/11591/430144
http://hdl.handle.net/11591/430144
Autor:
Antoine N. Saliba, Keith Pietropaolo, Kevin H. Kuo, Ellis J. Neufeld, Vip Viprakasit, Janet L. Kwiatkowski, Alan R. Cohen, Brenda I. Jeglinski, Yesim Aydinok, Patricia J. Giardina, Gregory Berk, Ali T. Taher
Publikováno v:
American journal of hematology. 92(12)
PubMed ID: 28940308
Our phase I, open-label, multi-center, dose-escalation study evaluated the pharmacokinetics (PK) of SP-420, a tridentate oral iron chelating agent of the desferrithiocin class, in patients with transfusion dependent ß-thalas
Our phase I, open-label, multi-center, dose-escalation study evaluated the pharmacokinetics (PK) of SP-420, a tridentate oral iron chelating agent of the desferrithiocin class, in patients with transfusion dependent ß-thalas